Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab.
Watson GA, Sanz-Garcia E, Zhang WJ, Liu ZA, Yang SC, Wang B, Liu S, Kubli S, Berman H, Pfister T, Genta S, Spreafico A, Hansen AR, Bedard PL, Lheureux S, Abdul Razak A, Cescon D, Butler MO, Xu W, Mak TW, Siu LL, Chen E.
Watson GA, et al. Among authors: genta s.
J Immunother Cancer. 2022 Jun;10(6):e004378. doi: 10.1136/jitc-2021-004378.
J Immunother Cancer. 2022.
PMID: 35705312
Free PMC article.